Irinotecan Hydrochloride Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Irinotecan Hydrochloride Injection (injection) from Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.) with status No longer listed by FDA. The shortage was first posted on Sep 26, 2025.
Shortage details
- Status
- No longer listed by FDA
- Company
- Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.)
- Package NDC
- 25021-230-02
- Dosage Form
- Injection
- Presentation
- Irinotecan Hydrochloride, Injection, 40 mg/2 mL (NDC 25021-230-02)
- Initial Posting
- Sep 26, 2025